Moreover, miR-503 targeted the mTOR pathway to regulate β-cell function in GDM patients (26) and miRNA-221 protected islet dysfunction by targeting PAK1 to regulate apoptosis, proliferation and insulin secretion in pancreatic β cells of GDM (27). Here, PAK1 is linked to gestational diabetes.